Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report

Maria Pippias, Vianda S Stel, José Maria Abad Diez, Nikolaos Afentakis, Jose Antonio Herrero-Calvo, Manuel Arias, Natalia Tomilina, Encarnación Bouzas Caamaño, Jadranka Buturovic-Ponikvar, Svjetlana Čala, Fergus J Caskey, Pablo Castro de la Nuez, Harijs Cernevskis, Frederic Collart, Ramón Alonso de la Torre, Maria de Los Ángeles García Bazaga, Johan De Meester, Joan Manuel Díaz, Ljubica Djukanovic, Manuel Ferrer AlamarPatrik Finne, Liliana Garneata, Eliezer Golan, Raquel González Fernández, Gonzalo Gutiérrez Avila, James Heaf, Andries Hoitsma, Nino Kantaria, Mykola Kolesnyk, Reinhard Kramar, Anneke Kramer, Mathilde Lassalle, Torbjørn Leivestad, Frantisek Lopot, Fernando Macário, Angela Magaz, Eduardo Martín-Escobar, Wendy Metcalfe, Marlies Noordzij, Runolfur Palsson, Ülle Pechter, Karl G Prütz, Marina Ratkovic, Halima Resić, Boleslaw Rutkowski, Carmen Santiuste de Pablos, Viera Spustová, Gültekin Süleymanlar, Karlijn Van Stralen, Nestor Thereska, Christoph Wanner, Kitty J Jager

Research output: Contribution to journalArticle (Academic Journal)peer-review

Abstract

BACKGROUND: This article summarizes the 2012 European Renal Association-European Dialysis and Transplant Association Registry Annual Report (available at www.era-edta-reg.org) with a specific focus on older patients (defined as ≥65 years).

METHODS: Data provided by 45 national or regional renal registries in 30 countries in Europe and bordering the Mediterranean Sea were used. Individual patient level data were received from 31 renal registries, whereas 14 renal registries contributed data in an aggregated form. The incidence, prevalence and survival probabilities of patients with end-stage renal disease (ESRD) receiving renal replacement therapy (RRT) and renal transplantation rates for 2012 are presented.

RESULTS: In 2012, the overall unadjusted incidence rate of patients with ESRD receiving RRT was 109.6 per million population (pmp) (n = 69 035), ranging from 219.9 pmp in Portugal to 24.2 pmp in Montenegro. The proportion of incident patients ≥75 years varied from 15 to 44% between countries. The overall unadjusted prevalence on 31 December 2012 was 716.7 pmp (n = 451 270), ranging from 1670.2 pmp in Portugal to 146.7 pmp in the Ukraine. The proportion of prevalent patients ≥75 years varied from 11 to 32% between countries. The overall renal transplantation rate in 2012 was 28.3 pmp (n = 15 673), with the highest rate seen in the Spanish region of Catalonia. The proportion of patients ≥65 years receiving a transplant ranged from 0 to 35%. Five-year adjusted survival for all RRT patients was 59.7% (95% confidence interval, CI: 59.3-60.0) which fell to 39.3% (95% CI: 38.7-39.9) in patients 65-74 years and 21.3% (95% CI: 20.8-21.9) in patients ≥75 years.

Original languageEnglish
Pages (from-to)248-61
Number of pages14
JournalClinical Kidney Journal
Volume8
Issue number3
DOIs
Publication statusPublished - 1 Jun 2015

Fingerprint Dive into the research topics of 'Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report'. Together they form a unique fingerprint.

Cite this